Groundbreaking Innovations in Diabetes Care: Highlights from the 2024 Diabetes Technology Meeting
The Diabetes Technology Society’s annual Diabetes Technology Meeting was held in Burlingame, California, between October 15th and 17th, 2024.
The event showcased groundbreaking innovations in diabetes care, and featured scientists and industry leaders who gathered to present the latest advancements in continuous glucose monitors (CGMs), automated insulin delivery (AID) systems, and artificial intelligence (AI).
This year’s event highlighted how emerging technologies are revolutionizing diabetes management and offering greater convenience, accuracy, and personalized care.
From cutting-edge research to real-world applications, the meeting underscored the vital role of technology in improving outcomes for people living with diabetes.
Here’s a look at some of the exciting developments revealed during the conference.
One Health Biosensing
One Health Biosensing is revolutionizing diabetes care with its next-generation intradermal CGM device.
Their reusable, needle-free sensors are designed for affordability and ease, making CGM accessible for more people with type 2 diabetes.
By using AI to provide precision insights even on non-CGM days, the system enhances health outcomes.
Featured in the Startup Showcase at the Diabetes Technology Meeting, One Health Biosensing’s innovative, low-cost solution has the potential to transform diabetes management through personalized, real-time glucose tracking.
For more details, visit their website at www.onehealthbiosensing.com.
GlucoCopilot.ai
At the 2024 Diabetes Technology Meeting, GlucoCopilot.ai was highlighted as a breakthrough tool in diabetes management.
This AI-driven platform analyzes data from CGMs, insulin pumps, and lifestyle factors to provide personalized insights and actionable recommendations.
By using machine learning, GlucoCopilot.ai helps users make informed decisions about their diabetes care in real time, optimizing blood sugar control and improving overall health outcomes.
Its debut at the event signals a new era of intelligent diabetes management tools.
Perspirion Diagnostics
Perspirion Diagnostics showcased its innovative sweat-based glucose monitoring system.
This cutting-edge device analyzes glucose levels through perspiration, offering a non-invasive alternative to traditional blood glucose testing.
With real-time data syncing to smartphones, it enables continuous tracking and early detection of glucose fluctuations.
Perspirion Diagnostics breakthrough technology promises to revolutionize diabetes management by providing a more convenient and comfortable way for people with diabetes to monitor their blood sugar levels effortlessly.
For more details, visit their website at www.perspiriontech.com.
Daia
Daia Health is an innovative diabetes management app designed to improve safety for people with type 1 diabetes.
It allows users to share real-time blood sugar information with emergency contacts during critical low blood sugar events.
The app sends actionable alerts, such as the location of glucagon or a medical ID, making it easier for caregivers to respond.
Daia was developed by a type 1 diabetic seeking greater independence while ensuring safety, and it offers customizable alerts for various situations like driving, exercising, or sleeping.
For more details, visit their website at www.diai.health.
Therapon Health
Therapon Health is dedicated to transforming diabetes management through advanced technology and seamless integration with Electronic Health Records (EHR).
Their platform autonomously monitors and transmits patient data, streamlining the care process.
Therapon Health was featured in the Startup Showcase at the Diabetes Technology Meeting, highlighting its innovative approach.
By enhancing data collaboration and real-time insights, Therapon has the potential to significantly improve outcomes for people with diabetes, providing healthcare teams with the tools they need for more effective patient care.
For more details, visit their website at www.theraponhealth.com.
Gluroo
Gluroo is a free, collaborative app designed to simplify diabetes management through real-time data sharing and integration with devices like CGMs, watches, and health apps.
It allows users to track blood sugar, meals, and exercise while receiving personalized reminders and motivational nudges.
Gluroo’s unique features enable families, caregivers, and healthcare providers to monitor and support diabetes management in real-time.
By streamlining data logging and connecting diabetes devices,
Gluroo has the potential to revolutionize how people with diabetes and their support teams manage the condition, fostering a more connected and proactive approach.
For more details, visit their website at www.gluroo.com.
Zimmer & Peacock
Zimmer & Peacock is a leader in developing and manufacturing electrochemical sensors and biosensors for medical diagnostics, wearable technologies, and more.
They specialize in functionalizing electrodes with enzymes, RNA, DNA, and other components to create specific sensors, including for CGMs..
At the Diabetes Technology Meeting’s Startup Showcase, Zimmer & Peacock demonstrated their cutting-edge wearable biosensors, such as CGM and hydration sensors.
By enabling real-time, on-body data collection, they have the potential to revolutionize diabetes management and health monitoring with their innovative sensor technology.
For more details, visit their website at www.zimmerpeacock.com.
BOYDSense
BOYDSense is revolutionizing diabetes management with its non-invasive glucose monitoring technology that uses breath analysis instead of blood.
Their device is designed to be painless, environmentally friendly, and cost-effective by eliminating consumables like test strips.
As a participant in the Startup Showcase at the Diabetes Technology Meeting, BOYDSense showcased how their innovative approach can simplify diabetes care.
By removing the barriers of pain and inconvenience, their solution offers a promising future for people with diabetes, encouraging better engagement and long-term management.
For more details, visit their website at www.boydsense.com.
Lumosfit
Lumosfit is focused on decreasing the risk of diabetes through lifestyle modification and personalized health insights.
By utilizing digital health technology, their platform offers tailored exercise, nutrition, and wellness plans to help users maintain a healthier lifestyle and lower their risk of diabetes.
At the Startup Showcase, Lumosfit presented its innovative approach to diabetes prevention.
With its emphasis on proactive health management, Lumosfit aims to shift the focus from treatment to prevention, potentially reducing the global diabetes burden and empowering individuals to take control of their health.
For more details, visit their website at www.lumosfit.com.
Provigate
Provigate is pioneering the development of next-generation blood glucose monitoring devices that are both accurate and user-friendly.
Their technology integrates non-invasive monitoring solutions with wearable devices, allowing real-time glucose tracking without the need for finger pricks.
Provigate was featured at the Startup Showcase during the Diabetes Technology Meeting, where they presented their innovative solutions.
By offering a more convenient and less intrusive way to manage blood sugar, Provigate aims to improve diabetes management and enhance quality of life for people living with the condition.
For more details, visit their website at www.provigate.com/en/.
Digital Hospital Inc.
Digital Hospital Inc. introduced its revolutionary virtual diabetes care platform.
Designed to offer 24/7 access to healthcare professionals, this digital hospital enables real-time consultations, personalized treatment plans, and continuous monitoring through integrated health devices like CGMs and insulin pumps.
By bringing healthcare directly to patients’ homes, Digital Hospital Inc. aims to improve diabetes management, reduce hospital visits, and provide seamless, comprehensive care to those living with diabetes.
For more details, visit their website at www.digitalhospitalinc.com.